Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta ‐analysis of randomised placebo‐control human clinical trials

ConclusionsThe lipid‐lowering, hypotensive, anti‐arrhythmic and anti‐inflammatory actions of EPA and DHA supplements were confirmed in this analysis of randomised placebo‐control blinded clinical trials.
Source: Journal of Human Nutrition and Dietetics - Category: Nutrition Authors: Tags: Research Paper Source Type: research